Robert Froud

Robert Froud

Auto-generated profile, based on publicly available information

Robert Froud

Faculty of Health Sciences and Technology, Kristiania University of Applied Sciences, Oslo, Norway

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2014 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
RFRobert Froud
Robert Froud
SPSue Patterson
Sue Patterson
SESandra Eldridge
Sandra Eldridge
CSClive Seale
Clive Seale
TPTamar Pincus
Tamar Pincus
MUMartin Underwood
Martin Underwood
Low back pain (LBP) is a common and costly problem that many interpret within a biopsychosocial model. There is renewed concern that core-sets of outcome measures do not capture what is important. To inform debate about the coverage of back pain outcome measure core-sets, and to suggest areas worthy of exploration within healthcare consultations, we have synthesised the qualitative literature on the impact of low back pain on people’s lives.

1 August 2010 in Manual Therapy
Verified
Journal Article
Closed access
DCDawn Carnes
Dawn Carnes
TMThomas S. Mars
Thomas S. Mars
BMBrenda Mullinger
Brenda Mullinger
RFRobert Froud
Robert Froud
MUMartin Underwood
Martin Underwood

31 January 2011 in BMC Medical Research Methodology
Verified
Journal Article
Open access
PDF file
TPTamar Pincus
Tamar Pincus
CMClare Miles
Clare Miles
RFRobert Froud
Robert Froud
MUMartin Underwood
Martin Underwood
DCDawn Carnes
Dawn Carnes
STSteph Jane Caroline Taylor
Steph Jane Caroline Taylor
Current methodological guidelines provide advice about the assessment of sub-group analysis within RCTs, but do not specify explicit criteria for assessment. Our objective was to provide researchers with a set of criteria that will facilitate the grading of evidence for moderators, in systematic reviews.

4 December 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RFRobert Froud
Robert Froud
GAGary Abel
Gary Abel
Receiver Operator Characteristic (ROC) curves are being used to identify Minimally Important Change (MIC) thresholds on scales that measure a change in health status. In quasi-continuous patient reported outcome measures, such as those that measure changes in chronic diseases with variable clinical trajectories, sensitivity and specificity are often valued equally. Notwithstanding methodologists agreeing that these should be valued equally, different approaches have been taken to estimating MIC thresholds using ROC curves. We aimed to compare the different approaches used with a new approach, exploring the extent to which the methods choose different thresholds, and considering the effect of differences on conclusions in responder analyses. Using graphical methods, hypothetical data, and data from a large randomised controlled trial of manual therapy for low back pain, we compared two existing approaches with a new approach that is based on the addition of the sums of squares of 1-sensitivity and 1-specificity. There can be divergence in the thresholds chosen by different estimators. The cut-point selected by different estimators is dependent on the relationship between the cut-points in ROC space and the different contours described by the estimators. In particular, asymmetry and the number of possible cut-points affects threshold selection. Choice of MIC estimator is important. Different methods for choosing cut-points can lead to materially different MIC thresholds and thus affect results of responder analyses and trial conclusions. An estimator based on the smallest sum of squares of 1-sensitivity and 1-specificity is preferable when sensitivity and specificity are valued equally. Unlike other methods currently in use, the cut-point chosen by the sum of squares method always and efficiently chooses the cut-point closest to the top-left corner of ROC space, regardless of the shape of the ROC curve.

1 August 2015 in PharmacoEconomics
Verified
Journal Article
Closed access
PDF file
Stavros PetrouStavros Petrou
Stavros Petrou
OROliver Rivero-Arias
Oliver Rivero-Arias
HDHelen Dakin
Helen Dakin
LLLouise Longworth
Louise Longworth
MOMark Oppe
Mark Oppe
AGAlastair Gray
Alastair Gray

12 April 2018 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
PAPål André Amundsen
Pål André Amundsen
DEDavid William Evans
David William Evans
DRDévan Rajendran
Dévan Rajendran
PBPhilip Bright
Philip Bright
TBTom Bjørkli
Tom Bjørkli
RFRobert Froud
Robert Froud
Low back pain is a common health complaint resulting in substantial economic burden. Each year, upwards of 20 randomised controlled trials (RCTs) evaluating interventions for non-specific low back pain are published. Use of the term non-specific low back pain has been criticised on the grounds of encouraging heterogeneity and hampering interpretation of findings due to possible heterogeneous causes, challenging meta-analyses. We explored selection criteria used in trials of treatments for nsLBP. A systematic review of English-language reports of RCTs in nsLBP population samples, published between 2006 and 2012, identified from MEDLINE, EMBASE, and the Cochrane Library databases, using a mixed-methods approach to analysis. Study inclusion and exclusion criteria were extracted, thematically categorised, and then descriptive statistics were used to summarise the prevalence by emerging category. We included 168 studies. Two inclusion themes (anatomical area, and symptoms and signs) were identified. Anatomical area was most reported as between costal margins and gluteal folds (n = 8, 5%), while low back pain (n = 150, 89%) with or without referred leg pain (n = 27, 16%) was the most reported symptom. Exclusion criteria comprised 21 themes. Previous or scheduled surgery (n = 84, 50%), pregnancy (n = 81, 48%), malignancy (n = 78, 46%), trauma (n = 63, 37%) and psychological conditions (n = 58, 34%) were the most common. Sub-themes of exclusion criteria mostly related to neurological signs and symptoms: nerve root compromise (n = 44, 26%), neurological signs (n = 34, 20%) or disc herniation (n = 30, 18%). Specific conditions that were most often exclusion criteria were spondylolisthesis (n = 35, 21%), spinal stenosis (n = 31, 18%) or osteoporosis (n = 27, 16%). RCTs of interventions for non-specific low back pain have incorporated diverse inclusion and exclusion criteria. Guidance on standardisation of inclusion and exclusion criteria for nsLBP trials will increase clinical homogeneity, facilitating greater interpretation of between-trial comparisons and meta-analyses. We propose a template for reporting inclusion and exclusion criteria.